Tradestie Institutional Equity Comparison Engine

ENTX vs VIVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENTX Overall Edge

ENTX Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ENTX trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus VIVS at N/M Forward P/E and -10117.0% operating margin (-51.4% YoY). In options structure, ENTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro) against VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ENTX N/M vs VIVS N/M Fwd P/E
Growth & Margin Winner ENTX
Op Margin 0.0% vs -10117.0% ยท YoY -100.0% vs -51.4%
Momentum & Technical Winner ENTX
1Y +26.1% vs -87.0% ยท 52W Pos 72% vs 5%
Options & Structure Winner ENTX
CONSOLIDATION (33rd %ile IV) vs BREAKDOWN (N/A IV)
ENTX NASDAQ
Entera Bio Ltd. Ordinary Shares
Biological Products, (No Disgnostic Substances)
$3.28
+0.61% 1D
Market Cap $567.7M
1M Return +7.54%
1Y Return +26.15%
Forward P/E N/M
Unified AI Score
45.2 / 100 HOLD
Tech 25.0 Fund 51.0 Flow 68.0 Mom 60.0
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENTX +26.15% VIVS -86.99% Spread: +113.14 pp (ENTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENTX Revenue VIVS Revenue ENTX Op. Margin VIVS Op. Margin Margin Edge
FY2019 N/A $0M N/A -882.4% VIVS
FY2020 $0M $0M -3059.7% -977.9% VIVS
FY2021 $0M N/A -2139.6% N/A ENTX
FY2022 $0M $0M -9714.2% -765.3% VIVS
FY2023 N/A $0M N/A -4792.2% VIVS
FY2024 $0M $0M -5295.6% -13840.4% ENTX
FY2025 $0M $0M -27450.0% -8761.1% VIVS
FY2026 N/A $0M N/A -8768.7% VIVS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENTX (6) vs VIVS (1)
Institutional Metric ENTX VIVS Criterion Row Winner
Market Capitalization Scale $567.7M $2.4M Larger Scale ENTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% -51.4% Higher Growth VIVS
Operating Margin (TTM) Profitability 0.0% -10117.0% Higher Margin ENTX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -20.3% -343.1% Higher ROE ENTX
52-Week Range Position Momentum 72% ($1โ€“$4) 5% ($0โ€“$3) Stronger Trend ENTX
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 54% Vol 0.83ฮฒ ยท 480% Vol Lower Realized Risk ENTX
Unified Institutional Score Composite Signal 45.2 / 100 (HOLD) 36.8 / 100 (SELL) Higher Composite ENTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENTX vs VIVS Buy Guide
ENTX CONSOLIDATION
82d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENTX nor VIVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.